1887

oa SA Pharmaceutical Journal - Pharmacovigilance - who is responsible and why should we care? : forum

 

Abstract

The World Health Organisation defines as "the science and activities related to the detection, assessment, understanding and prevention of Adverse Drug Reactions (ADR) and drug-related problems". With respect to pharmacovigilance, both sound clinical judgement of the adverse drug reaction (ADR) and insight into the effects of the drug are required to allow a conclusion to be drawn as to the relationship between the adverse event and the drug involved. Pharmacovigilance is a responsibility shared by manufacturers, drug regulators, public health programmes, clinical institutions, academic researchers, health care workers, the media and consumers alike.

Loading

Article metrics loading...

/content/mp_sapj/77/9/EJC82473
2010-10-01
2016-12-09
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error